Neuroendocrine Cancer NZ (formerly Unicorn Foundation) is a registered charity supporting those affected by neuroendocrine (NET) Cancer.
With heavy hearts we share that one of our Unicorns, Dave Newman lost his battle against Neuroendocrine Cancer (NETS) aged 61.
Dave was married with 2 daughters & was a very loved poppa by 4 grandchildren who lit up his world & who he loved spending time with. Dave was a reserved man who loved a good laugh with those he cared about. He had a passion for trains; was the general manager of Ferrymead Railway for some time would often drive the stream train at Ferrymead Heritage Park. Dave was very involved with his daughter's schools, he loved to play tennis and spent many years driving big trucks. Dave's world was his close family & friends he will be dearly missed by us all.
Dave was diagnosed with Metastic Gastrenteropancratic Neuroendocrine Cancer in 2018 after missed diagnosis. He went to Melbourne for numerous PRRT treatments until COVID-19 struck. Sadly the closing of the Trans-Tasman bubble ended Dave's hopes for his final treatment.
With the support of NECNZ & Dave's family Dave's story was taken to the media & Health Minister of NZ to fight to get PRRT brought here to NZ for all NET patients. Thankfully this was successful and Dave had his final treatment in November. Sadly PRRT was not enough for Dave's aggressive tumors which led to the most heartbreaking & devastating news for Dave & his family; he would only have 3 months to live which resulted in a strong fight to then end.
In lieu of flowers, Dave's family wish that contributions be made to Neuroendocrine Cancer NZ.
Neuroendocrine Cancer NZ (formerly Unicorn Foundation NZ) is a registered charity provides support and information to patients, families and medical professionals involved in the treatment for Neuroendocrine Tumours (NET Cancer).
Funds raised will contribute towards supporting clinical research, lobbying for funding and further treatment options to become available to NZ neuroendocrine patients, NET nurse services and building and supporting the NET cancer community.